These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6547995)
21. ErbB2 overexpression in human breast carcinoma is correlated with p21Cip1 up-regulation and tyrosine-15 hyperphosphorylation of p34Cdc2: poor responsiveness to chemotherapy with cyclophoshamide methotrexate, and 5-fluorouracil is associated with Erb2 overexpression and with p21Cip1 overexpression. Yang W; Klos KS; Zhou X; Yao J; Yang Y; Smith TL; Shi D; Yu D Cancer; 2003 Sep; 98(6):1123-30. PubMed ID: 12973835 [TBL] [Abstract][Full Text] [Related]
22. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy. Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422 [TBL] [Abstract][Full Text] [Related]
23. Primary chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil in operable breast carcinoma. Falo C; Moreno A; Benito E; Lloveras B; Varela M; Serra JM; Prieto L; Azpeitia D; Escobedo A Cancer; 2005 Feb; 103(4):657-63. PubMed ID: 15648085 [TBL] [Abstract][Full Text] [Related]
24. [Meningeal carcinosis: early clinical manifestations of inflammatory cancer of the breast]. Pandolfi C; Colecchia M; Bolognini G; de Fazio P; Montanari G; Pollini F; Nalli G Minerva Med; 1995; 86(7-8):319-22. PubMed ID: 7478076 [TBL] [Abstract][Full Text] [Related]
25. A comparison of the outcomes of non-randomised chemotherapy regimens in node positive breast cancer. Kuru B; Camlibel M; Dinc S; Gulcelik MA; Atalay C; Alagol H J Exp Clin Cancer Res; 2005 Sep; 24(3):363-72. PubMed ID: 16270522 [TBL] [Abstract][Full Text] [Related]
26. [Toilet mastectomy: palliative treatment in women with advanced breast cancer]. Novoa Vargas A Ginecol Obstet Mex; 2002 Aug; 70():392-7. PubMed ID: 12448043 [TBL] [Abstract][Full Text] [Related]
27. retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil: Danish Breast Cancer Cooperative Group. Knoop AS; Knudsen H; Balslev E; Rasmussen BB; Overgaard J; Nielsen KV; Schonau A; Gunnarsdóttir K; Olsen KE; Mouridsen H; Ejlertsen B; J Clin Oncol; 2005 Oct; 23(30):7483-90. PubMed ID: 16234514 [TBL] [Abstract][Full Text] [Related]
29. [Combined irradiation and chemotherapy as postoperative treatment of breast cancer]. von der Maase H; Sveinsson T Ugeskr Laeger; 1978 Jul; 140(28):1676-8. PubMed ID: 695028 [No Abstract] [Full Text] [Related]
30. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. Crump M; Tu D; Shepherd L; Levine M; Bramwell V; Pritchard K J Clin Oncol; 2003 Aug; 21(16):3066-71. PubMed ID: 12915595 [TBL] [Abstract][Full Text] [Related]
31. [Complications of irradiation in combined irradiation and chemotherapy of breast cancer]. von der Maase H Ugeskr Laeger; 1978 Jul; 140(28):1678-80. PubMed ID: 695029 [No Abstract] [Full Text] [Related]
32. Does outcome of breast cancer depend on dose and dose intensity of adjuvant chemotherapy? Mittra I Natl Med J India; 1994; 7(5):221-2. PubMed ID: 7827602 [No Abstract] [Full Text] [Related]
33. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. ; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947 [TBL] [Abstract][Full Text] [Related]
34. Adjuvant therapy for breast cancer. Melnychuk D; Panasci LC N Engl J Med; 1994 Sep; 331(11):741-2; author reply 744-5. PubMed ID: 8058084 [No Abstract] [Full Text] [Related]
35. Prognostic value of various immunological tests in breast cancer patients treated with adjuvant postoperative chemotherapy. Rotstein S; Blomgren H; Nilsson B; Petrini B; Wasserman J; Baral E Chemioterapia; 1984 Aug; 3(4):227-31. PubMed ID: 6549437 [TBL] [Abstract][Full Text] [Related]
36. Symposium on breast carcinoma. Weinrach RS Ariz Med; 1975 Apr; 32(4):299-302. PubMed ID: 1119949 [No Abstract] [Full Text] [Related]
37. [Comparative evaluation of thiphosphamide, cyclophosphane, methotrexate and 5-fluorouracil in the treatment of breast cancer]. Sokolova VD; Perevodchikova NI Vestn Akad Med Nauk SSSR; 1971; 26(3):59-65. PubMed ID: 4996463 [No Abstract] [Full Text] [Related]
38. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma. Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577 [TBL] [Abstract][Full Text] [Related]
39. Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer. Coskun U; Gunel N; Onuk E; Yilmaz E; Bayram O; Yamac D; Cihan A; Ucan B; Yildirim Y; Celenkoglu G; Ozkan S Neoplasma; 2003; 50(3):210-6. PubMed ID: 12937855 [TBL] [Abstract][Full Text] [Related]
40. [High-dose chemotherapy rescued with peripheral blood stem cell transplantation for high-risk patients with breast cancer]. Kim S; Shiba E; Taguchi T; Kimoto Y; Inoue T; Shimazu K; Takamura Y; Tanji Y; Izukura M; Ogawa H; Sugiyama H; Kubota T; Kimura T; Takai S Gan To Kagaku Ryoho; 1996 Apr; 23(5):635-8. PubMed ID: 8678525 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]